FIELD: chemistry.SUBSTANCE: invention relates to compounds of formula,where n equals 1； p equals 0； j is an integer from 0 to 3； k is an integer from 0 to 2； A is a C6-14aryl group which includes phenyl, 2,3-dihydro-1H-indenyl, 6,7-dihydronaphthyl which is optionally substituted with 1-2 L, or a 6-10-member heterocyclic group which includes piperidinyl, 2,3,-dihydrobenzofuranyl, 3,4-dihydro-2H-chromenyl, which is optionally substituted with 1-5 L； ring B is a benzene ring； X is an oxygen atom or -NR7-； R1 is absent； R2 is a hydrogen atom； R3, R4, R5, R6 and R7 are independently a group randomly selected from a hydrogen atom and a C1-6alkyl group； L is independently a halogen atom, a C1-10alkyl group, which is optionally substituted with 1-5 RI substitutes, C1-10alkoxy group, which is optionally substituted with 1-5 RI substitutes, a phenyl group, which is optionally substituted with 1-5 RII substitutes, a 6-member heterocyclic group selected from pyridyl, pyrimidinyl, piperdinyl and 3,6-dihydro-2H-pyranyl, which is optionally substituted with 1-5 RII substitutes, phenoxy, pyridyloxy, which is optionally substituted with 1-5 RII substitutes, a non-aromatic heterocyclic oxy group selected from piperidinyloxy and oxanyloxy, which is optionally substituted with 1-5 RII substitutes, benzyloxy； Ra is a C1-6alkyl group； RI and RII substitutes are as indicated in claim 1 of the invention； or to pharmaceutically acceptable salts. The invention also relates to a pharmaceutical composition containing a compound of formula (I) and to intermediate compounds of formulafor producing compounds of formula (I).EFFECT: compounds of formula (I), having agonistic action on GPR40.29 cl, 22 tbl, 144 exИзобретение относится к соединениям формулы (I), где n является 1； p является 0； j представляет собой целое число от 0 до 3； k представляет собой целое число от 0 до 2； A представляет собой C6-14арильную группу, включающую фенил, 2,3-дигидро-1Н-инденил, 6,7-дигидронафтил, которая необязате
